Lv1
60 积分 2024-07-04 加入
Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer
4小时前
已完结
Dual HER2 inhibition: mechanisms of synergy, patient selection, and resistance
2个月前
已完结
Camrelizumab Plus Carboplatin and Pemetrexed as First-Line Treatment for Advanced Nonsquamous NSCLC: Extended Follow-Up of CameL Phase 3 Trial
9个月前
已完结
皖公网安备34019202002308
